7-Hydroxycoumarin Induces Vasorelaxation in Animals with Essential Hypertension: Focus on Potassium Channels and

Rafael L C Jesus1, Isnar L P Silva1, Fênix A Araújo2

  • 1Laboratory of Cardiovascular Physiology and Pharmacology, Federal University of Bahia, Salvador 40110-902, Brazil.

Insights

7-hydroxycoumarin (7-HC) demonstrates significant antihypertensive effects by relaxing blood vessels through potassium channel activation and calcium influx modulation. This natural compound offers a promising avenue for managing hypertension.

Area of Science:

  • Pharmacology
  • Cardiovascular Research
  • Natural Products Chemistry

Background:

  • Cardiovascular diseases (CVD) are a leading global cause of mortality, with hypertension as the primary risk factor.
  • Despite available treatments, effective blood pressure control remains a challenge for many hypertensive patients.
  • Natural products are vital sources for novel drug discovery, including antihypertensive agents.

Purpose of the Study:

  • To investigate the vascular effects of 7-hydroxycoumarin (7-HC), a natural product with potential antihypertensive properties.
  • To elucidate the mechanisms underlying the vasorelaxant effects of 7-HC in an experimental model of essential hypertension.

Main Methods:

  • Isometric tension measurements were performed on superior mesenteric arteries from spontaneously hypertensive rats (SHR).
  • The relaxant effects of varying concentrations of 7-HC (0.001 μM-300 μM) were assessed.
  • The study examined the involvement of ion channels (KATP, BKCa, Kv) and calcium signaling pathways (IP3, ryanodine receptors).

Main Results:

  • 7-HC induced significant vasorelaxation in the mesenteric arteries of hypertensive rats.
  • The relaxant effect was attributed to the activation of K+-channels (KATP, BKCa, Kv) and modulation of Ca2+ influx.
  • 7-HC reduced responsiveness to α1-adrenergic agonists and enhanced responses to muscarinic agonists and nitric oxide (NO) donors.
  • Endothelium-independent vasorelaxant factors were implicated in 7-HC's mechanism.

Conclusions:

  • 7-hydroxycoumarin exhibits potent endothelium-independent vasorelaxant properties in a model of essential hypertension.
  • Its mechanism involves K+-channel activation and modulation of intracellular calcium release and influx.
  • 7-HC demonstrates potential as a therapeutic agent for hypertension by reducing vasoconstriction and improving vascular relaxation.

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
617
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
673
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
691
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
49
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
519